# Bisoprolol

Drug · id `cardio:bisoprolol` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, organ or system: Heart  
Browse, condition area: High blood pressure  

## In plain language

Bisoprolol is a beta-blocker taken by mouth. The US label read, for bisoprolol fumarate tablets, lists one use: the management of hypertension, alone or in combination with other antihypertensive agents.

## Technical summary

RxNorm ingredient 19484; UNII UR59KN573L. The label names the substance as bisoprolol fumarate, so UNII UR59KN573L is the UNII of the fumarate salt and is a broad match. MeSH descriptor D017298 is Bisoprolol. Class: beta-Adrenergic Blocker (FDA established pharmacologic class, RxClass). The label read is the Solco Healthcare US, LLC label for bisoprolol fumarate, application ANDA217368, effective 2023-06-26 in openFDA. openFDA lists no single-ingredient bisoprolol label under a new drug application (a search on 2026-11-08 returned only a bisoprolol and hydrochlorothiazide combination), so this generic label was read. Other generic labels were not read. This page records label indications and the class only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People for whom the US label of bisoprolol fumarate tablets lists an indication: hypertension

Recipient: Recipient not specified; Population: Patients described in the indications section of the label. The label does not state an age range in the passage read.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passage read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of Bisoprolol fumarate, in the Solco Healthcare US, LLC version dated 2023-06-26 in openFDA, lists the medicine for the management of hypertension, alone or in combination with other antihypertensive agents.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients described in the indications section of the label. The label does not state an age range in the passage read.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passage read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-08
- Sources:
  1. Supports: openFDA drug label record for Bisoprolol fumarate, Solco Healthcare US, LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id 084308e4-3b8b-40d6-acbf-d775772a8a73 (manufacturer Solco Healthcare US, LLC, application ANDA217368), returned on 2026-11-08. The label text is dated 2023-06-26 (effective\_time). Other openFDA records of bisoprolol labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22084308e4-3b8b-40d6-acbf-d775772a8a73%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\], INDICATIONS AND USAGE. Retrieved 2026-11-08T20:37:03Z. Source state: Current. Version fingerprint: 5fad3e8635e7f8013200b11d2037d0759ef66b1362590865a526e320f258436c.
     How it applies: The label sentences that give the indications named in the statement, each quoted in the research quote table.
  2. Background: openFDA drug label record for Bisoprolol fumarate, Solco Healthcare US, LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id 084308e4-3b8b-40d6-acbf-d775772a8a73 (manufacturer Solco Healthcare US, LLC, application ANDA217368), returned on 2026-11-08. The label text is dated 2023-06-26 (effective\_time). Other openFDA records of bisoprolol labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22084308e4-3b8b-40d6-acbf-d775772a8a73%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-08T20:37:03Z. Source state: Current. Version fingerprint: 5fad3e8635e7f8013200b11d2037d0759ef66b1362590865a526e320f258436c.
     How it applies: Effective date of the label text read, 20230626.

## Connected pages

- Bisoprolol is a beta-adrenergic blocker (FDA established pharmacologic class in RxClass): Beta-blockers (drug class) (`cardio:beta-blockers`)
- FDA label lists management of hypertension as an indication: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-bisoprolol-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 2 registry products
- 15 registry trials

## Provenance

Content hash: 231afa104c185ea8c9b78c8cb2a6ab57d1ca844fa3bd6dd48816992fd02f86bb
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
